MGTX Straddle Strategy
MGTX (MeiraGTx Holdings plc), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
MGTX (MeiraGTx Holdings plc) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $922.8M, a beta of 1.24 versus the broader market, a 52-week range of 4.58-11.85, average daily share volume of 694K, a public-listing history dating back to 2018, approximately 375 full-time employees. These structural characteristics shape how MGTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.24 places MGTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on MGTX?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current MGTX snapshot
As of May 15, 2026, spot at $9.47, ATM IV 200.40%, IV rank 37.06%, expected move 57.45%. The straddle on MGTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on MGTX specifically: MGTX IV at 200.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 57.45% (roughly $5.44 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MGTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on MGTX should anchor to the underlying notional of $9.47 per share and to the trader's directional view on MGTX stock.
MGTX straddle setup
The MGTX straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MGTX near $9.47, the first option leg uses a $9.47 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MGTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MGTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $9.47 | N/A |
| Buy 1 | Put | $9.47 | N/A |
MGTX straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
MGTX straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on MGTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on MGTX
Straddles on MGTX are pure-volatility plays that profit from large moves in either direction; traders typically buy MGTX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
MGTX thesis for this straddle
The market-implied 1-standard-deviation range for MGTX extends from approximately $4.03 on the downside to $14.91 on the upside. A MGTX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current MGTX IV rank near 37.06% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on MGTX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MGTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MGTX-specific events.
MGTX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MGTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MGTX alongside the broader basket even when MGTX-specific fundamentals are unchanged. Always rebuild the position from current MGTX chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on MGTX?
- A straddle on MGTX is the straddle strategy applied to MGTX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MGTX stock trading near $9.47, the strikes shown on this page are snapped to the nearest listed MGTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MGTX straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MGTX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 200.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MGTX straddle?
- The breakeven for the MGTX straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MGTX market-implied 1-standard-deviation expected move is approximately 57.45%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on MGTX?
- Straddles on MGTX are pure-volatility plays that profit from large moves in either direction; traders typically buy MGTX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current MGTX implied volatility affect this straddle?
- MGTX ATM IV is at 200.40% with IV rank near 37.06%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.